Long-term renal survival of γ3-heavy chain deposition disease: a case report View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-07-17

AUTHORS

Takayuki Katsuno, Shige Mizuno, Masatsuna Mabuchi, Naotake Tsuboi, Atsushi Komatsuda, Shoichi Maruyama

ABSTRACT

BackgroundMonoclonal immunoglobulin deposition disease (MIDD) is characterized by the non-amyloid deposition of monoclonal immunoglobulin fragments in the basement membranes. Heavy chain deposition disease (HCDD) is a type of MIDD. HCDD is an extremely rare disease, and only three cases have been reported in Japan up to the present. The prognosis of HCDD is very poor, and optimal treatment has not been established. Only a few cases of HCDD with favorable long-term renal prognosis have been reported to date.Case presentationThe authors describe a 61-year-old woman who presented with massive proteinuria, progressive kidney impairment, and hypocomplementemia. Kidney biopsy was performed for a precise diagnosis. On light microscopy, glomerules were lobulated and presented with nodular sclerosing glomerulopathy with membranoproliferative glomerulonephritis-like features. Immunofluorescence studies were positive for IgG, C3, and C1q within the mesangial nodules and in a linear distribution along the capillary walls without associated deposition of light chains. Staining for IgG showed the presence of linear deposits along tubular basement membranes. The analysis of the IgG subclass stain demonstrated intense positivity for IgG3 only. Electron microscopy revealed non-organized electron-dense deposits in the expanded mesangial area and inner aspect of the glomerular basement membranes. In accordance with the histological findings, we diagnosed γ3-HCDD. There was no evidence of plasma cell dyscrasia as a result of bone marrow aspiration. Serum and urine monoclonal proteins were not detected by immunoelectrophoresis and immunofixation electrophoresis. The serum free light chain ratio was within normal range. At first, prednisolone was administrated at a dose of 40 mg/day. However, a therapeutic effect was not observed. Urinary protein was not decreased and renal function further deteriorated. Therefore, melphalan plus prednisolone (MP) therapy was initiated. After 4 courses of MP therapy, the clinical parameters, including proteinuria, serum creatinine, albumin, and complement level (C3 and C4) were ameliorated. To date, the patient has been followed for 28 months, and long-term renal survival has been observed.ConclusionsIn this case, hematologic disease such as multiple myeloma was not detected; however, MP therapy was effective. Recently, the novel concept of monoclonal gammopathy of renal significance (MGRS) has been reported. MIDD, which includes HCDD, is one category of MGRS. In MGRS, aggressive chemotherapy may induce favorable renal outcomes. More... »

PAGES

239

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12882-017-0645-z

DOI

http://dx.doi.org/10.1186/s12882-017-0645-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1090746488

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28716013


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glomerulonephritis, Membranoproliferative", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heavy Chain Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin G", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melphalan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prednisolone", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Japan", 
          "id": "http://www.grid.ac/institutes/grid.27476.30", 
          "name": [
            "Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Katsuno", 
        "givenName": "Takayuki", 
        "id": "sg:person.01064130220.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064130220.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Kaikoukai Jyousai Hospital, Nagoya, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Japan", 
            "Department of Internal Medicine, Kaikoukai Jyousai Hospital, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mizuno", 
        "givenName": "Shige", 
        "id": "sg:person.011552473215.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011552473215.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, Konan Kosei Hospital, Konan, Japan", 
          "id": "http://www.grid.ac/institutes/grid.459633.e", 
          "name": [
            "Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Japan", 
            "Department of Nephrology, Konan Kosei Hospital, Konan, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mabuchi", 
        "givenName": "Masatsuna", 
        "id": "sg:person.013753560433.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013753560433.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Japan", 
          "id": "http://www.grid.ac/institutes/grid.27476.30", 
          "name": [
            "Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tsuboi", 
        "givenName": "Naotake", 
        "id": "sg:person.0716501002.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716501002.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Nephrology, Rheumatology, Akita University Graduate School of Medicine, Akita, Japan", 
          "id": "http://www.grid.ac/institutes/grid.251924.9", 
          "name": [
            "Department of Hematology, Nephrology, Rheumatology, Akita University Graduate School of Medicine, Akita, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Komatsuda", 
        "givenName": "Atsushi", 
        "id": "sg:person.01163237403.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163237403.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Japan", 
          "id": "http://www.grid.ac/institutes/grid.27476.30", 
          "name": [
            "Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maruyama", 
        "givenName": "Shoichi", 
        "id": "sg:person.01106355134.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106355134.42"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bmt.2011.87", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045250958", 
          "https://doi.org/10.1038/bmt.2011.87"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2011.252", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016794441", 
          "https://doi.org/10.1038/bmt.2011.252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10157-013-0812-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033528788", 
          "https://doi.org/10.1007/s10157-013-0812-x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-07-17", 
    "datePublishedReg": "2017-07-17", 
    "description": "BackgroundMonoclonal immunoglobulin deposition disease (MIDD) is characterized by the non-amyloid deposition of monoclonal immunoglobulin fragments in the basement membranes. Heavy chain deposition disease (HCDD) is a type of MIDD. HCDD is an extremely rare disease, and only three cases have been reported in Japan up to the present. The prognosis of HCDD is very poor, and optimal treatment has not been established. Only a few cases of HCDD with favorable long-term renal prognosis have been reported to date.Case presentationThe authors describe a 61-year-old woman who presented with massive proteinuria, progressive kidney impairment, and hypocomplementemia. Kidney biopsy was performed for a precise diagnosis. On light microscopy, glomerules were lobulated and presented with nodular sclerosing glomerulopathy with membranoproliferative glomerulonephritis-like features. Immunofluorescence studies were positive for IgG, C3, and C1q within the mesangial nodules and in a linear distribution along the capillary walls without associated deposition of light chains. Staining for IgG showed the presence of linear deposits along tubular basement membranes. The analysis of the IgG subclass stain demonstrated intense positivity for IgG3 only. Electron microscopy revealed non-organized electron-dense deposits in the expanded mesangial area and inner aspect of the glomerular basement membranes. In accordance with the histological findings, we diagnosed \u03b33-HCDD. There was no evidence of plasma cell dyscrasia as a result of bone marrow aspiration. Serum and urine monoclonal proteins were not detected by immunoelectrophoresis and immunofixation electrophoresis. The serum free light chain ratio was within normal range. At first, prednisolone was administrated at a dose of 40\u00a0mg/day. However, a therapeutic effect was not observed. Urinary protein was not decreased and renal function further deteriorated. Therefore, melphalan plus prednisolone (MP) therapy was initiated. After 4 courses of MP therapy, the clinical parameters, including proteinuria, serum creatinine, albumin, and complement level (C3 and C4) were ameliorated. To date, the patient has been followed for 28\u00a0months, and long-term renal survival has been observed.ConclusionsIn this case, hematologic disease such as multiple myeloma was not detected; however, MP therapy was effective. Recently, the novel concept of monoclonal gammopathy of renal significance (MGRS) has been reported. MIDD, which includes HCDD, is one category of MGRS. In MGRS, aggressive chemotherapy may induce favorable renal outcomes.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12882-017-0645-z", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024626", 
        "issn": [
          "1471-2369"
        ], 
        "name": "BMC Nephrology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "keywords": [
      "heavy chain deposition disease", 
      "long-term renal survival", 
      "chain deposition disease", 
      "deposition disease", 
      "renal survival", 
      "MP therapy", 
      "cases of HCDD", 
      "long-term renal prognosis", 
      "serum free light chain ratio", 
      "basement membrane", 
      "free light chain ratio", 
      "Case presentationThe authors", 
      "progressive kidney impairment", 
      "urine monoclonal protein", 
      "favorable renal outcome", 
      "immunoglobulin deposition disease", 
      "bone marrow aspiration", 
      "plasma cell dyscrasia", 
      "light chain ratio", 
      "tubular basement membrane", 
      "monoclonal immunoglobulin fragments", 
      "glomerular basement membrane", 
      "electron-dense deposits", 
      "renal prognosis", 
      "kidney impairment", 
      "prednisolone therapy", 
      "aggressive chemotherapy", 
      "renal outcomes", 
      "renal function", 
      "serum creatinine", 
      "kidney biopsy", 
      "complement levels", 
      "histological findings", 
      "marrow aspiration", 
      "clinical parameters", 
      "renal significance", 
      "massive proteinuria", 
      "multiple myeloma", 
      "optimal treatment", 
      "mesangial nodules", 
      "case report", 
      "monoclonal gammopathy", 
      "cell dyscrasia", 
      "therapeutic effect", 
      "hematologic diseases", 
      "intense positivity", 
      "mesangial area", 
      "urinary protein", 
      "rare disease", 
      "normal range", 
      "monoclonal protein", 
      "linear deposits", 
      "disease", 
      "precise diagnosis", 
      "therapy", 
      "immunofixation electrophoresis", 
      "immunofluorescence studies", 
      "immunoglobulin fragments", 
      "inner aspect", 
      "proteinuria", 
      "prognosis", 
      "chain ratio", 
      "IgG", 
      "light chain", 
      "survival", 
      "capillary wall", 
      "light microscopy", 
      "MIDD", 
      "hypocomplementemia", 
      "prednisolone", 
      "glomerulopathy", 
      "chemotherapy", 
      "biopsy", 
      "melphalan", 
      "creatinine", 
      "patients", 
      "myeloma", 
      "dyscrasias", 
      "gammopathy", 
      "IgG3", 
      "diagnosis", 
      "dose", 
      "cases", 
      "impairment", 
      "months", 
      "women", 
      "positivity", 
      "C1q", 
      "outcomes", 
      "treatment", 
      "ConclusionsIn", 
      "nodules", 
      "protein", 
      "stain", 
      "immunoelectrophoresis", 
      "days", 
      "albumin", 
      "report", 
      "date", 
      "glomerules", 
      "MGRS", 
      "aspiration", 
      "membrane", 
      "C3", 
      "findings", 
      "course", 
      "evidence", 
      "levels", 
      "significance", 
      "study", 
      "associated deposition", 
      "effect", 
      "presence", 
      "function", 
      "electrophoresis", 
      "categories", 
      "wall", 
      "types", 
      "ratio", 
      "Japan", 
      "present", 
      "analysis", 
      "fragments", 
      "features", 
      "area", 
      "authors", 
      "results", 
      "novel concept", 
      "microscopy", 
      "aspects", 
      "accordance", 
      "linear distribution", 
      "deposition", 
      "electron microscopy", 
      "deposits", 
      "parameters", 
      "range", 
      "distribution", 
      "chain", 
      "concept"
    ], 
    "name": "Long-term renal survival of \u03b33-heavy chain deposition disease: a case report", 
    "pagination": "239", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1090746488"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12882-017-0645-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28716013"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12882-017-0645-z", 
      "https://app.dimensions.ai/details/publication/pub.1090746488"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_721.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12882-017-0645-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12882-017-0645-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12882-017-0645-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12882-017-0645-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12882-017-0645-z'


 

This table displays all metadata directly associated to this object as RDF triples.

294 TRIPLES      21 PREDICATES      177 URIs      166 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12882-017-0645-z schema:about N0fa81a59847a4c81b8b85d0732d3a34a
2 N436a5264f6a34bae8e1387fd63fe2b49
3 N5531410afabc455cbabfa0bb03ef2031
4 N72ec1edd1da94308ace13fbcdaf25d83
5 Nb512be45e3b34fc1a498cd5d5e77e0ab
6 Nc2365223d7a54217820c74b3e426040e
7 Nc6814e500f83454b97a53fc15cfe2c64
8 Nd2ff64c0d48242a1af83dbf74a05ae4b
9 Nf0426dc8fbb547f1abe2e1f9c596c674
10 anzsrc-for:11
11 anzsrc-for:1103
12 schema:author N65e7b2d5db1343a1913ca5a13b7dfa75
13 schema:citation sg:pub.10.1007/s10157-013-0812-x
14 sg:pub.10.1038/bmt.2011.252
15 sg:pub.10.1038/bmt.2011.87
16 schema:datePublished 2017-07-17
17 schema:datePublishedReg 2017-07-17
18 schema:description BackgroundMonoclonal immunoglobulin deposition disease (MIDD) is characterized by the non-amyloid deposition of monoclonal immunoglobulin fragments in the basement membranes. Heavy chain deposition disease (HCDD) is a type of MIDD. HCDD is an extremely rare disease, and only three cases have been reported in Japan up to the present. The prognosis of HCDD is very poor, and optimal treatment has not been established. Only a few cases of HCDD with favorable long-term renal prognosis have been reported to date.Case presentationThe authors describe a 61-year-old woman who presented with massive proteinuria, progressive kidney impairment, and hypocomplementemia. Kidney biopsy was performed for a precise diagnosis. On light microscopy, glomerules were lobulated and presented with nodular sclerosing glomerulopathy with membranoproliferative glomerulonephritis-like features. Immunofluorescence studies were positive for IgG, C3, and C1q within the mesangial nodules and in a linear distribution along the capillary walls without associated deposition of light chains. Staining for IgG showed the presence of linear deposits along tubular basement membranes. The analysis of the IgG subclass stain demonstrated intense positivity for IgG3 only. Electron microscopy revealed non-organized electron-dense deposits in the expanded mesangial area and inner aspect of the glomerular basement membranes. In accordance with the histological findings, we diagnosed γ3-HCDD. There was no evidence of plasma cell dyscrasia as a result of bone marrow aspiration. Serum and urine monoclonal proteins were not detected by immunoelectrophoresis and immunofixation electrophoresis. The serum free light chain ratio was within normal range. At first, prednisolone was administrated at a dose of 40 mg/day. However, a therapeutic effect was not observed. Urinary protein was not decreased and renal function further deteriorated. Therefore, melphalan plus prednisolone (MP) therapy was initiated. After 4 courses of MP therapy, the clinical parameters, including proteinuria, serum creatinine, albumin, and complement level (C3 and C4) were ameliorated. To date, the patient has been followed for 28 months, and long-term renal survival has been observed.ConclusionsIn this case, hematologic disease such as multiple myeloma was not detected; however, MP therapy was effective. Recently, the novel concept of monoclonal gammopathy of renal significance (MGRS) has been reported. MIDD, which includes HCDD, is one category of MGRS. In MGRS, aggressive chemotherapy may induce favorable renal outcomes.
19 schema:genre article
20 schema:isAccessibleForFree true
21 schema:isPartOf N93e946813c15484a84c87423e51d148c
22 Ncfbafcba8cd74112acb74b2216903f80
23 sg:journal.1024626
24 schema:keywords C1q
25 C3
26 Case presentationThe authors
27 ConclusionsIn
28 IgG
29 IgG3
30 Japan
31 MGRS
32 MIDD
33 MP therapy
34 accordance
35 aggressive chemotherapy
36 albumin
37 analysis
38 area
39 aspects
40 aspiration
41 associated deposition
42 authors
43 basement membrane
44 biopsy
45 bone marrow aspiration
46 capillary wall
47 case report
48 cases
49 cases of HCDD
50 categories
51 cell dyscrasia
52 chain
53 chain deposition disease
54 chain ratio
55 chemotherapy
56 clinical parameters
57 complement levels
58 concept
59 course
60 creatinine
61 date
62 days
63 deposition
64 deposition disease
65 deposits
66 diagnosis
67 disease
68 distribution
69 dose
70 dyscrasias
71 effect
72 electron microscopy
73 electron-dense deposits
74 electrophoresis
75 evidence
76 favorable renal outcome
77 features
78 findings
79 fragments
80 free light chain ratio
81 function
82 gammopathy
83 glomerular basement membrane
84 glomerules
85 glomerulopathy
86 heavy chain deposition disease
87 hematologic diseases
88 histological findings
89 hypocomplementemia
90 immunoelectrophoresis
91 immunofixation electrophoresis
92 immunofluorescence studies
93 immunoglobulin deposition disease
94 immunoglobulin fragments
95 impairment
96 inner aspect
97 intense positivity
98 kidney biopsy
99 kidney impairment
100 levels
101 light chain
102 light chain ratio
103 light microscopy
104 linear deposits
105 linear distribution
106 long-term renal prognosis
107 long-term renal survival
108 marrow aspiration
109 massive proteinuria
110 melphalan
111 membrane
112 mesangial area
113 mesangial nodules
114 microscopy
115 monoclonal gammopathy
116 monoclonal immunoglobulin fragments
117 monoclonal protein
118 months
119 multiple myeloma
120 myeloma
121 nodules
122 normal range
123 novel concept
124 optimal treatment
125 outcomes
126 parameters
127 patients
128 plasma cell dyscrasia
129 positivity
130 precise diagnosis
131 prednisolone
132 prednisolone therapy
133 presence
134 present
135 prognosis
136 progressive kidney impairment
137 protein
138 proteinuria
139 range
140 rare disease
141 ratio
142 renal function
143 renal outcomes
144 renal prognosis
145 renal significance
146 renal survival
147 report
148 results
149 serum creatinine
150 serum free light chain ratio
151 significance
152 stain
153 study
154 survival
155 therapeutic effect
156 therapy
157 treatment
158 tubular basement membrane
159 types
160 urinary protein
161 urine monoclonal protein
162 wall
163 women
164 schema:name Long-term renal survival of γ3-heavy chain deposition disease: a case report
165 schema:pagination 239
166 schema:productId N0475ad4f7f5d48a181f3e443dbfd6547
167 N70dae1eb47164d19a4f3e66c8ca3083b
168 Ndaf47c642b9b4e17b153c4bf162fdb0e
169 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090746488
170 https://doi.org/10.1186/s12882-017-0645-z
171 schema:sdDatePublished 2022-08-04T17:05
172 schema:sdLicense https://scigraph.springernature.com/explorer/license/
173 schema:sdPublisher N14989cdd4bd349c7805a0aff72693998
174 schema:url https://doi.org/10.1186/s12882-017-0645-z
175 sgo:license sg:explorer/license/
176 sgo:sdDataset articles
177 rdf:type schema:ScholarlyArticle
178 N0475ad4f7f5d48a181f3e443dbfd6547 schema:name doi
179 schema:value 10.1186/s12882-017-0645-z
180 rdf:type schema:PropertyValue
181 N0fa81a59847a4c81b8b85d0732d3a34a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Drug Therapy, Combination
183 rdf:type schema:DefinedTerm
184 N14989cdd4bd349c7805a0aff72693998 schema:name Springer Nature - SN SciGraph project
185 rdf:type schema:Organization
186 N1a7424d3a05d4e5e876066c125877843 rdf:first sg:person.01163237403.41
187 rdf:rest Ndf046d133aee411099ef8ba193d96c1f
188 N2222f6d1ad2848df9edf35a88a42be46 rdf:first sg:person.0716501002.47
189 rdf:rest N1a7424d3a05d4e5e876066c125877843
190 N436a5264f6a34bae8e1387fd63fe2b49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Prednisolone
192 rdf:type schema:DefinedTerm
193 N5531410afabc455cbabfa0bb03ef2031 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Melphalan
195 rdf:type schema:DefinedTerm
196 N65e7b2d5db1343a1913ca5a13b7dfa75 rdf:first sg:person.01064130220.19
197 rdf:rest N7af9f77934eb4a1abff9069b252b811b
198 N70dae1eb47164d19a4f3e66c8ca3083b schema:name dimensions_id
199 schema:value pub.1090746488
200 rdf:type schema:PropertyValue
201 N72ec1edd1da94308ace13fbcdaf25d83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Female
203 rdf:type schema:DefinedTerm
204 N7af9f77934eb4a1abff9069b252b811b rdf:first sg:person.011552473215.69
205 rdf:rest Ndd930559316d4395adc5b02f400ec899
206 N93e946813c15484a84c87423e51d148c schema:volumeNumber 18
207 rdf:type schema:PublicationVolume
208 Nb512be45e3b34fc1a498cd5d5e77e0ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Heavy Chain Disease
210 rdf:type schema:DefinedTerm
211 Nc2365223d7a54217820c74b3e426040e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
212 schema:name Immunoglobulin G
213 rdf:type schema:DefinedTerm
214 Nc6814e500f83454b97a53fc15cfe2c64 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
215 schema:name Glomerulonephritis, Membranoproliferative
216 rdf:type schema:DefinedTerm
217 Ncfbafcba8cd74112acb74b2216903f80 schema:issueNumber 1
218 rdf:type schema:PublicationIssue
219 Nd2ff64c0d48242a1af83dbf74a05ae4b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
220 schema:name Middle Aged
221 rdf:type schema:DefinedTerm
222 Ndaf47c642b9b4e17b153c4bf162fdb0e schema:name pubmed_id
223 schema:value 28716013
224 rdf:type schema:PropertyValue
225 Ndd930559316d4395adc5b02f400ec899 rdf:first sg:person.013753560433.13
226 rdf:rest N2222f6d1ad2848df9edf35a88a42be46
227 Ndf046d133aee411099ef8ba193d96c1f rdf:first sg:person.01106355134.42
228 rdf:rest rdf:nil
229 Nf0426dc8fbb547f1abe2e1f9c596c674 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
230 schema:name Humans
231 rdf:type schema:DefinedTerm
232 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
233 schema:name Medical and Health Sciences
234 rdf:type schema:DefinedTerm
235 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
236 schema:name Clinical Sciences
237 rdf:type schema:DefinedTerm
238 sg:journal.1024626 schema:issn 1471-2369
239 schema:name BMC Nephrology
240 schema:publisher Springer Nature
241 rdf:type schema:Periodical
242 sg:person.01064130220.19 schema:affiliation grid-institutes:grid.27476.30
243 schema:familyName Katsuno
244 schema:givenName Takayuki
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064130220.19
246 rdf:type schema:Person
247 sg:person.01106355134.42 schema:affiliation grid-institutes:grid.27476.30
248 schema:familyName Maruyama
249 schema:givenName Shoichi
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106355134.42
251 rdf:type schema:Person
252 sg:person.011552473215.69 schema:affiliation grid-institutes:None
253 schema:familyName Mizuno
254 schema:givenName Shige
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011552473215.69
256 rdf:type schema:Person
257 sg:person.01163237403.41 schema:affiliation grid-institutes:grid.251924.9
258 schema:familyName Komatsuda
259 schema:givenName Atsushi
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163237403.41
261 rdf:type schema:Person
262 sg:person.013753560433.13 schema:affiliation grid-institutes:grid.459633.e
263 schema:familyName Mabuchi
264 schema:givenName Masatsuna
265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013753560433.13
266 rdf:type schema:Person
267 sg:person.0716501002.47 schema:affiliation grid-institutes:grid.27476.30
268 schema:familyName Tsuboi
269 schema:givenName Naotake
270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716501002.47
271 rdf:type schema:Person
272 sg:pub.10.1007/s10157-013-0812-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1033528788
273 https://doi.org/10.1007/s10157-013-0812-x
274 rdf:type schema:CreativeWork
275 sg:pub.10.1038/bmt.2011.252 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016794441
276 https://doi.org/10.1038/bmt.2011.252
277 rdf:type schema:CreativeWork
278 sg:pub.10.1038/bmt.2011.87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045250958
279 https://doi.org/10.1038/bmt.2011.87
280 rdf:type schema:CreativeWork
281 grid-institutes:None schema:alternateName Department of Internal Medicine, Kaikoukai Jyousai Hospital, Nagoya, Japan
282 schema:name Department of Internal Medicine, Kaikoukai Jyousai Hospital, Nagoya, Japan
283 Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Japan
284 rdf:type schema:Organization
285 grid-institutes:grid.251924.9 schema:alternateName Department of Hematology, Nephrology, Rheumatology, Akita University Graduate School of Medicine, Akita, Japan
286 schema:name Department of Hematology, Nephrology, Rheumatology, Akita University Graduate School of Medicine, Akita, Japan
287 rdf:type schema:Organization
288 grid-institutes:grid.27476.30 schema:alternateName Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Japan
289 schema:name Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Japan
290 rdf:type schema:Organization
291 grid-institutes:grid.459633.e schema:alternateName Department of Nephrology, Konan Kosei Hospital, Konan, Japan
292 schema:name Department of Nephrology, Konan Kosei Hospital, Konan, Japan
293 Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Japan
294 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...